Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
European Journal of Nuclear Medicine and Molecular Imaging
Published in: European Journal of Nuclear Medicine and Molecular Imaging 11/2003

01-11-2003 | Controversies—For

FDG-PET in infectious and inflammatory disease

Authors: Wim J. G. Oyen, Luigi Mansi

Published in: European Journal of Nuclear Medicine and Molecular Imaging | Issue 11/2003

Login to get access

Excerpt

Suspected focal infection or inflammation is a challenging medical problem, especially in fever of unknown origin (FUO). In 1961, Petersdorf and Beeson formulated the classical definition of FUO: an illness of more than three weeks’ duration with fever higher than 38.3°C (101°F) on several occasions, and diagnosis uncertain after one week of study in the hospital. In 1992, the requirement that the evaluation must take place in the hospital was removed and immunocompromised patients were excluded, since these patients need an entirely different diagnostic and therapeutic approach [1]. …
Literature
1.
Petersdorf RG. Fever of unknown origin. An old friend revisited. Arch Intern Med 1992; 152:21–22.CrossRefPubMed
2.
Tahara T, Ichiya Y, Kuwabara Y, et al. High [18F]-fluorodeoxyglucose uptake in abdominal abscesses: a PET study. J Comput Assist Tomogr 1989; 13:829–831.PubMed
3.
Kubota R, Yamada S, Kubota K, Ishiwata K, Tamahashi N, Ido T. Intratumoral distribution of fluorine-18-fluorodeoxyglucose in vivo: high accumulation in macrophages and granulation tissues studied by microautoradiography. J Nucl Med 1992; 33:1972–1980.PubMed
4.
Matthies A, Hickeson M, Cuchiara A, Alavi A. Dual time point18F-FDG PET for the evaluation of pulmonary nodules. J Nucl Med 2002; 43:871–875.PubMed
5.
Lorenzen J, Buchert R, Bohuslavizki KH. Value of FDG PET in patients with fever of unknown origin. Nucl Med Commun 2001; 22:779–783.PubMed
6.
Meller J, Altenvoerde G, Munzel U, et al. Fever of unknown origin: prospective comparison of [18F]FDG imaging with a double-head coincidence camera and gallium-67 citrate SPET. Eur J Nucl Med 2000; 27:1617–1625.PubMed
7.
Blockmans D, Knockaert D, Maes A, et al. Clinical value of18F-fluoro-deoxyglucose positron emission tomography for patients with fever of unknown origin. Clin Infect Dis 2001; 32:191–196.CrossRefPubMed
8.
Bleeker-Rovers CP, van der Meer JW, Corstens FH, Oyen WJ. Promising role of FDG PET in patients with fever of unknown origin. J Nucl Med 2003; 44 (Suppl):45P.
9.
Bleeker-Rovers CP, de Kleijn EMHA, Corstens FH, van der Meer JW, Oyen WJ. Clinical value of FDG-PET in patients with fever of unknown origin and patients suspected of focal infection or inflammation. Eur J Nucl Med Mol Imaging 2003; 30:in press.
10.
Sugawara Y, Braun DK, Kison PV, Russo JE, Zasadny KR, Wahl RL. Rapid detection of human infections with fluorine-18 fluorodeoxyglucose and positron emission tomography: preliminary results. Eur J Nucl Med 1998; 25:1238–1243.CrossRefPubMed
11.
Stumpe KD, Dazzi H, Schaffner A, von Schulthess GK. Infection imaging using whole-body FDG-PET. Eur J Nucl Med 2000; 27:822–832.CrossRefPubMed
12.
Chacko TK, Zhuang H, Nakhoda KZ, Moussavian B, Alavi A. Applications of fluorodeoxyglucose positron emission tomography in the diagnosis of infection. Nucl Med Commun 2003; 24:615–624.CrossRefPubMed
13.
Blockmans D, Stroobants S, Maes A, Mortelmans L. Positron emission tomography in giant cell arteritis and polymyalgia rheumatica: evidence for inflammation of the aortic arch. Am J Med 2000; 108: 246–249.CrossRefPubMed
14.
Spaepen K, Stroobants S, Verhoef G, Mortelmans L. Positron emission tomography with (F-18) FDG for therapy response monitoring in lymphoma patients. Eur J Nucl Med Mol Imaging 2003; 30 (Suppl 1):S97–S105.
Metadata
Title
FDG-PET in infectious and inflammatory disease
Authors
Wim J. G. Oyen
Luigi Mansi
Publication date
01-11-2003
Publisher
Springer-Verlag
Published in
European Journal of Nuclear Medicine and Molecular Imaging / Issue 11/2003
Print ISSN: 1619-7070
Electronic ISSN: 1619-7089
DOI
https://doi.org/10.1007/s00259-003-1359-y

Other articles of this Issue 11/2003

European Journal of Nuclear Medicine and Molecular Imaging 11/2003 Go to the issue

Controversies—Against

FDG-PET in infectious and inflammatory disease

Letter to the Editor

Reply

Short Communication

Assessment of left ventricular diastolic function by gated single-photon emission tomography: comparison with Doppler echocardiography

Original Article

A new, practical, low-dose 14C-urea breath test for the diagnosis of Helicobacter pylori infection: clinical validation and comparison with the standard method

Original Article

A new approach for improving diagnostic accuracy in Alzheimer’s disease and frontal lobe dementia utilising the intrinsic properties of the SPET dataset

Original Article

Regional cerebral blood flow assessed with 99mTc-ECD SPET as a marker of progression of mild cognitive impairment to Alzheimer's disease